Mereo BioPharma Group plc (MREO)
NASDAQ·Healthcare·Biotechnology
$0.27
-2.03%
Mkt Cap $62.52M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 19, 2026 | $23.33M | — | — | -$0.01 | -$0.01 | +0.00% | — | — |
| Q4 2025 Nov 10, 2025 | $5.30M | $300.00K | -94.34% | -$0.01 | -$0.01 | -20.05% | — | — |
| Q3 2025 Aug 12, 2025 | — | $685.71K | — | -$0.01 | -$0.02 | -100.00% | — | — |
| Q2 2025 May 13, 2025 | $11.89M | — | — | -$0.01 | -$0.02 | -100.00% | — | — |
| Q1 2025 Mar 26, 2025 | $11.89M | $1.33M | -88.80% | -$0.02 | -$0.01 | +50.00% | — | — |
| Q4 2024 Nov 12, 2024 | — | — | — | -$1.36 | -$7.69 | -465.44% | — | — |
| Q3 2024 Aug 13, 2024 | — | — | — | -$0.78 | -$0.02 | +97.44% | — | — |
| Q2 2024 May 15, 2024 | — | — | — | — | -$0.01 | — | — | — |
| Q1 2024 Mar 27, 2024 | — | $456.43K | — | -$0.02 | -$0.01 | +44.75% | — | — |
| Q4 2023 Nov 17, 2023 | — | $648.81K | — | — | -$0.01 | — | — | — |
| Q3 2023 Sep 7, 2023 | — | $11.13M | — | -$0.02 | -$0.03 | -37.05% | — | — |
| Q2 2023 Jun 27, 2023 | — | $4.41M | — | — | -$0.01 | — | — | — |
| Q1 2023 Mar 28, 2023 | — | $1.02M | — | -$0.05 | -$0.03 | +28.87% | — | — |
| Q4 2022 Nov 2, 2022 | — | $746.78K | — | -$0.38 | -$0.02 | +95.58% | — | — |
| Q2 2022 Jun 30, 2022 | — | — | — | — | -$0.05 | — | — | — |
| Q2 2022 Apr 1, 2022 | — | — | — | -$4.50 | $0.00 | +100.04% | — | — |
| Q1 2022 Mar 31, 2022 | — | $606.46K | — | — | -$0.03 | — | — | — |
| Q4 2021 Nov 8, 2021 | — | $416.83K | — | -$2.50 | $0.00 | +100.04% | — | — |
| Q2 2021 Jun 30, 2021 | — | $69.97M | — | — | $0.04 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | $34.72M | — | -$0.07 | $0.03 | +139.13% | — | — |